Articles > Blood Cancer

  1. #ASCO20: Cancer in the Time of COVID-19, and Progress in Myeloma and Lymphoma

    As National Cancer Research Month (May) winds down, it seems timely to reflect on progress in cancer treatments. And that is precisely what we will do this weekend. This is the weekend Chicago would typically be flooded with more than 40,000 researchers, clinicians, pharmaceutical company reps, media and cancer advocacy organizations as the annual host of the world’s biggest cancer conference. But like all other large events around the globe, the American Society of Clinical Oncology...

    Read More
  1. AACR 2020 Goes Virtual

    The American Association of Clinical Research, like so many other organizations, was forced to move its major annual meeting from sunny San Diego to a virtual format this past week in response to the COVID-19 pandemic. AACR made the decision to host the meeting on a virtual platform over two days to give scientists an opportunity to present their latest discoveries across the spectrum of cancer research. Several presentations relevant to the blood cancers drew my interest. Off-the-s...

    Read More
  2. Recent Drug Approvals for Blood Cancer Mark Significant Progress for Patients

    Driving forward science While we all are navigating uncertainty and challenges in these unprecedented times, there is promising news: science is racing forward. Dedicated researchers around the world are collaborating in new ways, sharing data openly and advancing our understanding of the novel virus that causes coronavirus disease (COVID-19). In fact, more than 70 countries have joined the World Health Organization in accelerating research on effective treatments for COVID-19 and about 20...

    Read More
  3. Harnessing the Power of Women

    “Women have the power and when we join together, we can make all the difference.” With those words, Stephanie McMahon, Chief Brand Officer at WWE, captured the theme of The Leukemia & Lymphoma Society’s (LLS) “Women Curing Cancer” initiative, which brings together philanthropic women to move collectively the needle in cancer cures and access to treatments. On Wednesday, Stephanie joined LLS’s Chief Medical Officer Dr. Gwen Nichols, and LLS volunteer Julie Guillot, ...

    Read More
  1. Families Fighting for Cancer Cures: Generation LLS

    As an organization founded by a family for families, The Leukemia & Lymphoma Society (LLS) is celebrating 70 years of impact on generations of families, researchers and volunteers while looking to the future by redoubling its commitment to improve treatments and care for children with cancer. To accomplish its bold vision for children, LLS is launching The LLS Children’s Initiative to deliver cures and care for children by disrupting drug development for pediatric cancers and ex...

    Read More
  2. Less Is More and Don’t Eat Me! (#ASCO18)

    This post is one in a series of news updates from ASCO. Read more by clicking here and here. The American Society of Clinical Oncology (#ASCO18) annual meeting is an opportunity to show the progress on investigational cancer therapies, better ways to use old medicines and improved methods of diagnosis. One of the interesting themes to emerge over the past few days here in Chicago is the goal of giving less rather than more treatment. The quest to de-escalate treatment helps avoid bo...

    Read More
  3. Precision Medicine: Hope and Hype #ASCO18

    Using genomics – analyzing a cancer patient’s genetic profile to identify what is causing the malignancy and then using a drug that will work best for that patient’s subtype of cancer – has been evolving over at least two decades. The approach has accelerated in recent years as the technology has improved. And with it there have been stunning successes along with some disappointments. On Saturday at the American Society of Clinical Oncology meeting (#ASCO18) in Chicago, resu...

    Read More
  4. Stopping Treatment for CML – Another First for a Blood Cancer

    Certain patients with chronic myeloid leukemia (CML) who take nilotinib daily may have achieved such deep remissions that they may be able to stop their treatment, according to a recent FDA decision When the targeted oral therapy, imatinib (Gleevec®) was approved by the U.S. Food & Drug Administration (FDA) in 2001, it revolutionized treatment for patients with chronic myeloid leukemia (CML), turning an almost certain death sentence into a chronic disease for most patients who r...

    Read More
  5. Achieving the Impossible: What’s ahead in 2018?

    We’ve just concluded one of the most historic years on record in terms of new therapy approvals for blood cancers. In all, the U.S. Food and Drug Administration (FDA) approved 18 therapies to treat patients with blood cancers, including some entirely new agents and some new uses for already approved drugs. Among these approvals were the first new therapies – four to be precise – for acute myeloid leukemia (AML) after a 40-year drought in treatment advances for this deadly blood c...

    Read More
  6. Lodging & Transportation Resources for Cancer Survivors

    By Margaret Martin, RD, MS, LDN, Licensed Dietitian and Nutritionist; Certified Diabetes Educator, PearlPoint Cancer Support As part of cancer treatment, you may make frequent trips to your cancer treatment center for appointments and treatment. If your treatment center isn’t close to home, this may mean extra transportation and lodging expenses. Many resources are available to cancer patients to help cover the costs of travel for treatment. The first step is to talk to your healt...

    Read More